{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:54:53Z","timestamp":1785790493028,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K10101"],"award-info":[{"award-number":["16K10101"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07832"],"award-info":[{"award-number":["18K07832"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10197"],"award-info":[{"award-number":["17K10197"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hypoxic-ischemic encephalopathy (HIE) has a high morbidity rate and involves severe neurologic deficits, including cerebral palsy. Therapeutic hypothermia (TH) has been shown to decrease the mortality rate and provide neuroprotection in infants with HIE. However, death and disability rates in HIE infants treated with TH remain high. Although the cellular mechanism of the neuroprotective effect of TH remains unclear, astrocytic erythropoietin (EPO) is known to be a key mediator of neuroprotection under hypoxic conditions. In the present study, we investigated the hypothermia effect on EPO expression in astrocytes and determined whether hypothermia attenuates neuronal damage via EPO signaling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Astrocytes derived from rat cerebral cortex were cultured under oxygen\/glucose deprivation (OGD). The expression of EPO and hypoxia-inducible factor (HIF), a transcription factor of EPO, was assessed. After OGD, astrocytes were cultured under normothermic (37 \u00b0C) or hypothermic (33.5 \u00b0C) conditions, and then EPO and HIF expression was assessed. After OGD, rat cortical neurons were cultured in astrocyte-conditioned medium (ACM) derived from the hypothermic group, and neuronal apoptosis was evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>OGD induced EPO mRNA and protein expression, although at lower levels than hypoxia alone. HIF-1\u03b1 and HIF-2\u03b1 protein expression increased under hypoxia alone and OGD, although OGD increased HIF-2\u03b1 protein expression less than hypoxia alone. EPO gene and protein expression after OGD was significantly higher under hypothermia. Moreover, expression of HIF-1\u03b1 and HIF-2\u03b1 protein was enhanced under hypothermia. In the presence of ACM derived from hypothermic astrocytes following OGD, the number of cleaved caspase 3 and TdT-mediated dUTP nick-end labeling-positive apoptotic neurons was lower than in the presence of ACM from normothermic astrocytes following OGD. Blockade of EPO signaling using anti-EPO neutralization antibody attenuated the anti-apoptotic effect of ACM derived from hypothermic astrocytes following OGD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hypothermia after OGD stabilized HIF-EPO signaling in astrocytes, and upregulated EPO expression could suppress neuronal apoptosis. Investigating the neuroprotective effect of EPO from astrocytes under hypothermic conditions may contribute to the development of novel neuroprotection-based therapies for HIE.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12974-020-01831-3","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T08:05:33Z","timestamp":1588406733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions"],"prefix":"10.1186","volume":"17","author":[{"given":"Kohki","family":"Toriuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-6465","authenticated-orcid":false,"given":"Mineyoshi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,2]]},"reference":[{"key":"1831_CR1","doi-asserted-by":"crossref","unstructured":"Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013:1.","DOI":"10.1002\/14651858.CD003311.pub3"},{"issue":"14","key":"1831_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361(14):1349\u201358.","journal-title":"N Engl J Med."},{"issue":"9460","key":"1831_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0140-6736(05)17946-X","volume":"365","author":"PD Gluckman","year":"2005","unstructured":"Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet. 2005;365(9460):663\u201370.","journal-title":"Lancet."},{"issue":"15","key":"1831_CR4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353(15):1574\u201384.","journal-title":"N Engl J Med."},{"issue":"1","key":"1831_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clp.2013.10.005","volume":"41","author":"PP Drury","year":"2014","unstructured":"Drury PP, Gunn ER, Bennet L, Gunn AJ. Mechanisms of hypothermic neuroprotection. Clin Perinatol. 2014;41(1):161\u201375.","journal-title":"Clin Perinatol"},{"key":"1831_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fnins.2019.00586","volume":"13","author":"YJ Sun","year":"2019","unstructured":"Sun YJ, Zhang ZY, Fan B, Li GY. Neuroprotection by therapeutic hypothermia. Front Neurosci. 2019;13:586.","journal-title":"Front Neurosci"},{"key":"1831_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2017.00024","volume":"11","author":"S J\u00e4kel","year":"2017","unstructured":"J\u00e4kel S, Dimou L. Glial cells and their function in the adult brain: a journey through the history of their ablation. Front Cell Neurosci. 2017;11:24.","journal-title":"Front Cell Neurosci"},{"issue":"37","key":"1831_CR8","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1523\/JNEUROSCI.2838-06.2006","volume":"26","author":"JC Chavez","year":"2006","unstructured":"Chavez JC, Baranova O, Lin J, Pichiule P. The transcriptional activator hypoxia inducible factor 2 (HIF-2\/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci. 2006;26(37):9471\u201381.","journal-title":"J Neurosci."},{"issue":"6","key":"1831_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1152\/ajpregu.00577.2003","volume":"286","author":"J Fandrey","year":"2004","unstructured":"Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol. 2004;286(6):977\u201388.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"1831_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0959-437X(98)80016-6","volume":"8","author":"GL Semenza","year":"1998","unstructured":"Semenza GL. Hypoxia-inducible factor 1: Master regulator of O2 homeostasis. Curr Opin Genet Dev. 1998;8(5):588\u201394.","journal-title":"Curr Opin Genet Dev."},{"key":"1831_CR11","doi-asserted-by":"crossref","unstructured":"Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3\u2032 enhancer in multiple cell lines: Evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A. 1993;90(6):24234233.","DOI":"10.1073\/pnas.90.6.2423"},{"issue":"8","key":"1831_CR12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1242\/jeb.201.8.1197","volume":"201","author":"HF Bunn","year":"1998","unstructured":"Bunn HF, Gu J, Huang LE, Park JW, Zhu H. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J Exp Biol. 1998;201(8):1197\u2013201.","journal-title":"J Exp Biol."},{"issue":"1","key":"1831_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0306-4522(96)00306-5","volume":"76","author":"E Morishita","year":"1996","unstructured":"Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoetin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1996;76(1):105\u201316.","journal-title":"Neuroscience."},{"issue":"15","key":"1831_CR14","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1016\/S0021-9258(18)82112-3","volume":"268","author":"S Masuda","year":"1993","unstructured":"Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F, Tabira T, et al. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells. Journal of Biological Chemistry. 1993;268(15):11208\u201316.","journal-title":"Journal of Biological Chemistry."},{"issue":"11","key":"1831_CR15","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1111\/ejn.12747","volume":"40","author":"Y Nagaya","year":"2014","unstructured":"Nagaya Y, Aoyama M, Tamura T, Kakita H, Kato S, Hida H, et al. Inflammatory cytokine tumor necrosis factor \u03b1 suppresses neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia-inducible factor-2\u03b1. Eur J Neurosci. 2014;40(11):3620\u20136.","journal-title":"Eur J Neurosci."},{"issue":"3","key":"1831_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"1831_CR17","first-page":"1381","volume":"12","author":"CC Hern\u00e1ndez","year":"2017","unstructured":"Hern\u00e1ndez CC, Burgos CF, Gajardo AH, Silva-Grecchi T, Gavilan J, Toledo JR, et al. Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: The role of erythropoietin receptor. Vol. 12, Neural Regeneration Research. Medknow Publications. 2017;12(9):1381\u20139.","journal-title":"Medknow Publications."},{"issue":"6","key":"1831_CR18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.23736\/S0375-9393.18.12164-X","volume":"84","author":"SM Hakim","year":"2018","unstructured":"Hakim SM, Ammar MA, Reyad MS. Effect of therapeutic hypothermia on survival and neurological outcome in adults suffering cardiac arrest: a systematic review and meta-analysis. Minerva Anestesiol. 2018;84(6):720\u201330.","journal-title":"Minerva Anestesiol."},{"issue":"4","key":"1831_CR19","first-page":"489","volume":"27","author":"AI Ahmed","year":"2016","unstructured":"Ahmed AI, Bullock MR, Dietrich WD. Hypothermia in traumatic brain injury. Neurosurgery Clinics of North America. W.B. Saunders. 2016;27(4):489\u201397.","journal-title":"Saunders."},{"issue":"1\u20132","key":"1831_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2008.07.029","volume":"275","author":"SH Lee","year":"2008","unstructured":"Lee SH, Kim YH, Kim YJ, Yoon BW. Atorvastatin enhances hypothermia-induced neuroprotection after stroke. J Neurol Sci. 2008;275(1\u20132):64\u20138.","journal-title":"J Neurol Sci."},{"issue":"10","key":"1831_CR21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/jnr.22702","volume":"89","author":"S Kato","year":"2011","unstructured":"Kato S, Aoyama M, Kakita H, Hida H, Kato I, Ito T, et al. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J Neurosci Res. 2011;89(10):1566\u201374.","journal-title":"J Neurosci Res."},{"key":"1831_CR22","first-page":"65","volume":"2017","author":"T Tamura","year":"1662","unstructured":"Tamura T, Aoyama M, Ukai S, Kakita H, Sobue K, Asai K. Neuroprotective erythropoietin attenuates microglial activation, including morphological changes, phagocytosis, and cytokine production. Brain Res. 1662;2017:65\u201374.","journal-title":"Brain Res."},{"issue":"11","key":"1831_CR23","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/jnr.21687","volume":"86","author":"TS Kim","year":"2008","unstructured":"Kim TS, Misumi S, Jung CG, Masuda T, Isobe Y, Furuyama F, et al. Increase in dopaminergic neurons from mouse embryonic stem cell-derived neural progenitor\/stem cells is mediated by hypoxia inducible factor-1\u03b1. J Neurosci Res. 2008;86(11):2353\u201362.","journal-title":"J Neurosci Res."},{"issue":"1","key":"1831_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190039","volume":"13","author":"S-H Wu","year":"2018","unstructured":"Wu S-H, Lu I-C, Lee S-S, Kwan A-L, Chai C-Y, Huang S-H. Erythropoietin attenuates motor neuron programmed cell death in a burn animal model. PLoS One. 2018;13(1):e0190039.","journal-title":"PLoS One."},{"issue":"3","key":"1831_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jnc.14296","volume":"145","author":"D Komnig","year":"2018","unstructured":"Komnig D, Gertz K, Habib P, Nolte KW, Meyer T, Brockmann MA, et al. Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia. J Neurochem. 2018;145(3):258\u201370.","journal-title":"J Neurochem."},{"issue":"1","key":"1831_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12974-017-0976-5","volume":"14","author":"M Moransard","year":"2017","unstructured":"Moransard M, Bednar M, Frei K, Gassmann M, Ogunshola OO. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms. J Neuroinflammation. 2017;14(1):202.","journal-title":"J Neuroinflammation."},{"issue":"6","key":"1831_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/01616412.2017.1316904","volume":"39","author":"R Wang","year":"2017","unstructured":"Wang R, Zhao H, Li J, Duan Y, Fan Z, Tao Z, et al. Erythropoietin attenuates axonal injury after middle cerebral artery occlusion in mice. Neurol Res. 2017;39(6):545\u201351.","journal-title":"Neurol Res."},{"issue":"1","key":"1831_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","volume":"9","author":"GL Semenza","year":"2014","unstructured":"Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol Mech Dis. 2014;9(1):47\u201371.","journal-title":"Annu Rev Pathol Mech Dis."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-020-01831-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-01831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T20:05:11Z","timestamp":1666469111000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-01831-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1831"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-01831-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,2]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Animal Care and Use Committee of Nagoya City University Graduate School of Pharmaceutical Sciences (protocol number; H27-P-03), and all experiments were performed in accordance with institutional and U.S. National Institutes of Health guidelines for the care and use of laboratory animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}